Benefits of omalizumab on anxiety and depression in patients with severe asthma
Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxi...
Saved in:
Main Authors: | Fatih Uzer (Author), Omer Ozbudak (Author) |
---|---|
Format: | Book |
Published: |
Babol University of Medical Sciences,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are 25(OH) D concentrations associated with asthma control and pulmonary function test?
by: Fatih Uzer, et al.
Published: (2019) -
A review of omalizumab for the management of severe asthma
by: Lin CH, et al.
Published: (2016) -
Omalizumab and IgE in the Control of Severe Allergic Asthma
by: Yasuhiro Gon, et al.
Published: (2022) -
Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma
by: A. G. Tolkushin, et al.
Published: (2019) -
OMALIZUMAB-BASED TREATMENT OF TEENAGERS, SUFFERING FROM SEVERE ATOPIC BRONCHIAL ASTHMA
by: T.V. Kulichenko, et al.
Published: (2008)